JACC: Cardiovascular Interventions
Structural
Coronary Sinus Reducer Implantation for the Treatment of Chronic Refractory AnginaA Single-Center Experience
Francesco Giannini, Luca Baldetti, Francesco Ponticelli, Neil Ruparelia, Satoru Mitomo, Azeem Latib, Matteo Montorfano, Richard J. Jabbour, Andrea Aurelio, Luca Ferri, Antonio Mangieri, Damiano Regazzoli, Marco Ancona, Matteo Pagnesi, Alessia Faccini, Alaide Chieffo, Lorenzo Azzalini, Mauro Carlino and Antonio Colombo
Table 2
Table 2
Baseline Medical Therapy (N = 50)
| Antithrombotic therapy | |
| Acetylsalicylic acid | 35 (70) |
| Clopidogrel | 41 (82) |
| Ticagrelor | 6 (12) |
| Prasugrel | 2 (4) |
| Direct oral anticoagulants | 3 (6) |
| Vitamin K antagonists | 3 (6) |
| Anti-ischemic therapy | |
| Beta-blockers | 46 (92) |
| Calcium-channel antagonists | 26 (52) |
| Long-acting nitrates | 28 (56) |
| Ivabradine | 18 (36) |
| Ranolazine | 33 (66) |
| Number of anti-ischemic drugs | 3 (1–5) |
Values are n (%) or median (interquartile range).
Advertisement